Seeport » MarketPlace
Advanced Search
Search Marketplace

MarketPlace

Medical Devices Tags: fetal perfusion system
IPC:A61 M1/00
NAICS:423450

Fetal Perfusion System

Ension, Inc.

  • Technology Description

    The fetal perfusion system consists of a miniature centrifugal pump
    (priming volume approx. 20 ml) and blood oxygenator (priming volume
    approx. 12 ml), both designed specifically for the fetal application
    and capable of pulsatile (up to 120 beats per minute.)

  • Market Projection

    36?rand=60343
    2007 2008 2009 2010 2011
    Market Size $22500000.0 $22720000.0 $23210000.0 $23730000.0 $24400000.0
    Market Share (%) 1.1% 5.2% 15.2% 25.2% 44.2%

  • Value Proposition

    Ension's fetal perfusion system will over a low priming volume of under 20 mL and low oxygenator priming volume of 12 mL that will allow it to be used for open-heart surgeries on fetuses.

  • Competitive Analysis

    35?rand=367634

  • Video Introduction

  • Commercialization Team

    • * Sarah Wright, Principal Investigator 412-828-5209 ext. 13 swright@ension.com

      Contact for additional information

    • * Preferred point of Contact

  • Company Capsule

    Ension, Inc.

    240 William Pitt Way
    Pittsburgh, PA

    412-828-5209
    Call for additional information

    Ension appears to be developing a device for a market that has yet to materialize. Nevertheless, fetal perfusion systems do appear to be a necessary outgrowth of the ongoing research and desire to develop more advanced surgical techniques in order to prevent even more severe congenital heart diseases from manifesting after birth. Currently, 32,000 babies are born every year with a congenital birth defect. While only a small percentage of these patients would need a fetal surgical procedure, the prospect of being able to correct cardiac lesions safely before a child is born is appealing to many doctors.